1.
Frontiers of Medicine
; (4): 621-628, 2021.
Artículo
en Inglés
| WPRIM
| ID: wpr-888733
RESUMEN
Multi-gene assays have emerged as crucial tools for risk stratification in early-stage breast cancer. This study aimed to evaluate the prognostic significance of the 21-gene recurrence score (RS) in Chinese patients with pN0-1, estrogen receptor-positive (ER